2,280
Views
16
CrossRef citations to date
0
Altmetric
Research Articles

Toxicity of silver nanoparticles in mouse bone marrow-derived dendritic cells: Implications for phenotype

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 54-62 | Received 03 Oct 2018, Accepted 15 Feb 2019, Published online: 02 Apr 2019

References

  • Ahlberg S, Antonopulos A, Diendorf J, Dringen R, Epple M, Flöck R, Goedecke W, Graf C, Haberl N, Helmlinger J. 2014. PVP-coated, negatively-charged silver nanoparticles: A multi-center study of their physicochemical characteristics, cell culture and in vivo experiments. Beilstein J Nanotechnol. 5:1944.
  • Ahmed L, Milić M, Pongrac I, Marjanović A, Mlinarić H, Pavičić I, Vrček I. 2017. Impact of surface functionalization on the uptake mechanism and toxicity effects of silver nanoparticles in HepG2 cells. Food Chem Toxicol. 107:349–361.
  • Asare N, Instanes C, Sandberg W, Refsnes M, Schwarze P, Kruszewski M, Brunborg G. 2012. Cytotoxic and genotoxic effects of silver nanoparticles in testicular cells. Toxicology. 291:65–72.
  • Asharani P, Wu Y, Gong Z, Valiyaveettil S. 2008. Toxicity of silver nanoparticles in zebrafish models. Nanotechnology. 19:255102.
  • Aziz S, Aziz S, Akbarzadeh A. 2017. Advances in silver nanotechnology: Update on biomedical applications and future perspectives. Drug Res. 67:198–203.
  • Beer C, Foldbjerg R, Hayashi Y, Sutherland D, Autrup H. 2012. Toxicity of silver nanoparticles or silver ion? Toxicol Lett. 208:286–292.
  • Borrego B, Lorenzo G, Mota-Morales J, Almanza-Reyes H, Mateos F, López-Gil E, de la Loza N, Burmistrov V, Pestryakov A, Burn A, et al. 2016. Potential application of silver nano-particles to control infectivity of Rift Valley fever virus in vitro and in vivo. Nanomedicine. 12:1185–1192.
  • Chinai J, Janakiram M, Chen F, Chen W, Kaplan M, Zang X. 2015. New immunotherapies targeting the PD-1 pathway. Trends Pharmacol Sci. 36:587–595.
  • Collins A, El Yamani N, Dusinska M. 2017. Sensitive detection of DNA oxidation damage induced by nanomaterials. Free Radic Biol Med. 107:69–76.
  • Dube A, Reynolds J, Law W, Maponga C, Prasad P, Morse G. 2014. Multimodal nanoparticles that provide immunomodulation and intracellular drug delivery for infectious diseases. Nano medicine. 10:831–838.
  • El Badawy A, Silva R, Morris B, Scheckel K, Suidan M, Tolaymat T. 2011. Surface charge-dependent toxicity of silver nanoparticles. Environ Sci Technol. 45:283–287.
  • El Yamani N, Collins AR, Rundén-Pran E, Fjellsbø LM, Shaposhnikov S, Zielonddiny S, Dusinska M. 2017. In vitro genotoxicity testing of four reference metal nanomaterials, titanium dioxide, zinc oxide, cerium oxide and silver: Towards reliable hazard assessment. Mutagenesis. 32:117–126.
  • Fabbrizi M, Duff T, Oliver J, Wilde C. 2014. Advanced in vitro systems for efficacy and toxicity testing in nanomedicine. Eur J Nanomed. 6:171–183.
  • Fortoul T, Valverde M, Lopez M, Avila-Costa M, Avila-Casado M, Mussali-Galante P, Gonzalez-Villalva A, Rojas E, Ostrosky-Shejet P. 2004. Genotoxic differences by sex in nasal epithelium and blood leukocytes in subjects residing in a highly polluted area. Environ Res. 94:243–248.
  • Ge L, Li Q, Wang M, Ouyang J, Li X, Xing M. 2014. Nanosilver particles in medical applications: Synthesis, performance, and toxicity. Intl J Nanomed. 9:2399–2407.
  • Ghislat G, Lawrence T. 2018. Autophagy in dendritic cells. Cell Mol Immunol Nat. 15:944–952.
  • Ghosh M, Manivannan J, Sinha S, Chakraborty A, Mallick S, Bandyopadhyay M, Mukherjee A. 2012. In vitro and in vivo genotoxicity of silver nanoparticles. Mutat Res. 749:60–69.
  • Herzog F, Loza K, Balog S, Clift M, Epple M, Gehr P, Petri-Fink A, Rothen-Rutishauser B. 2014. Mimicking exposures to acute and lifetime concentrations of inhaled silver nanoparticles by two different in vitro approaches. Beilstein J Nanotechnol. 5:1357–1370.
  • Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman R. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med. 176:1693–1702.
  • Jiao Q, Li L, Mu Q, Zhang Q. 2014. Immunomodulation of nanoparticles in nanomedicine applications. BioMed Res Intl. 2014:1.
  • Juarez-Moreno K, Gonzalez E, Girón-Vazquez N, Chávez-Santoscoy R, Mota-Morales J, Perez-Mozqueda L, Garcia-Garcia M, Pestryakov A, Bogdanchikova N. 2017. Comparison of cytotoxicity and genotoxicity effects of silver nanoparticles on human cervix and breast cancer cell lines. Human Exp Toxicol. 36:931–948.
  • Kang K, Jung H, Lim J. 2012. Cell death by polyvinylpyrrolidine-coated silver nanoparticles is mediated by ROS-dependent signaling. Biomol Ther. 20:399.
  • Kang K, Lim J. 2012. Induction of functional changes of dendritic cells by silica nanoparticles. Immune Net. 12:104–112.
  • Klippstein R, Fernandez-Montesinos R, Castillo P, Zaderenko A, Pozo D. 2010. Silver nanoparticles interactions with the immune system: Implications for health and disease. Intech Open. 2010:309–324.
  • Koike E, Takano H, Inoue K, Yanagisawa R, Kobayashi T. 2008. Carbon black nanoparticles promote the maturation and function of mouse bone marrow-derived dendritic cells. Chemosphere. 73:371–376.
  • Levine B, Kroemer G. 2008. Autophagy in the pathogenesis of disease. Cell. 132:27–42.
  • Lin J, Huang Z, Wu H, Zhou W, Jin P, Wei P, Zhang Y, Zheng F, Zhang J, Xu J, et al. 2014. Inhibition of autophagy enhances the anti-cancer activity of silver nanoparticles. Autophagy. 10:2006–2020.
  • Liu W, Worms I, Herlin-Boime N, Truffier-Boutry D, Michaud-Soret I, Mintz E, Vidaud C, Rollin-Genetet F. 2017. Interaction of silver nanoparticles with metallothionein and ceruloplasmin: Impact on metal substitution by Ag(I), corona formation and enzymatic activity. Nanoscale. 9:6581–6594.
  • Ma D, Clark E. 2009. The role of CD40 and CD154/CD40L in dendritic cells. Semin Immunol. 21:265–272.
  • Piñón-Zárate G, Herrera-Enríquez M, Hernández-Téllez B, Jarquín-Yáñez K, Castell-Rodríguez A. 2014. GK-1 improves the immune response induced by bone marrow dendritic cells loaded with MAGE-AX in mice with melanoma. J Immunol Res. 2014:158980.
  • Riaz Ahmed K, Nagy A, Brown R, Zhang Q, Malghan S, Goering P. 2017. Silver nanoparticles: Significance of physicochemical properties and assay interference on the interpretation of in vitro cytotoxicity studies. Toxicol In Vitro. 38:179–192.
  • Sharma V, Siskova K, Zboril R, Gardea-Torresdey J. 2014. Organic-coated silver nanoparticles in biological and environmental conditions: Fate, stability and toxicity. Adv Colloid Inter-Face Sci. 204:15–34.
  • Shin J, Ebersold M, Pypaert M, Delamarre L, Hartley A, Mellman I. 2006. Surface expression of MHC Class II in dendritic cells is controlled by regulated ubiquitination. Nature. 444:115.
  • Steinman R, Banchereau J. 2007. Taking dendritic cells into medicine. Nature. 449:419.
  • Strauss G. 1991. Non-random cell killing in cryopreservation: Implications for performance of the battery of leukocyte tests (BLT), I. Toxic and immunotoxic effects. Mutat Res. 252:1–15.
  • van der Zande M, Vandebriel R, van Doren E, Kramer E, Herrera Rivera Z, Serrano-Rojero C, Gremmer E, Mast J, Peters R, Hollman P, et al. 2012. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano. 6:7427–7442.
  • Vazquez-Muñoz R, Borrego B, Juárez-Moreno K, García-García M, Morales J, Bogdanchikova N, Huerta-Saquero A. 2017. Toxicity of silver nanoparticles in biological systems: Does the complexity of biological systems matter? Toxicol Lett. 276:11–20.
  • Villadangos J, Schnorrer P, Wilson N. 2005. Control of MHC Class II antigen presentation in dendritic cells: A balance between creative and destructive forces. Immunol Rev. 207:191–205.
  • Wei L, Lu J, Xu H, Patel A, Chen Z, Chen G. 2015. Silver nanoparticles: Synthesis, properties, and therapeutic applications. Drug Discov Today. 20:595–601.
  • Zhang X, Liu Z, Shen W, Gurunathan S. 2016. Silver nanoparticles: synthesis, characterization, properties, applications, and therapeutic approaches. Intl J Mol Sci. 17:1534.
  • Zhang T, Wang L, Chen Q, Chen C. 2014. Cytotoxic potential of silver nanoparticles. Yonsei Med J. 55:283–291.
  • Zhou W, Liu Y, Stallworth A, Ye C, Lenhart J. 2016. Effects of pH, electrolyte, humic acid, and light exposure on the long-term fate of silver nanoparticles. Environ Sci Technol. 50:12214–12224.